Brain cancer researchers at Washington University are exploring how lymphocytes, cells that help the immune system respond to cancer, could replenish the immune system of patients with high-grade glioma who have undergone chemotherapy to improve their outcomes.
As individuals diagnosed and treated for cancer are living longer, more and more cancer survivors are being diagnosed with metastatic brain tumors – tumors that begin elsewhere in the body and spread to the brain. Studies show that five to 25 percent of all cancer patients develop secondary tumors in the brain – that’s 100,000-700,000 people every year.
Researchers from Massachusetts General Hospital and Harvard Medical School have identified found that proton radiotherapy reduces negative side-effects typically caused by photon therapy when treating medulloblastoma, a common type of brain cancer in children.
Researchers from Massachusetts General Hospital and Brigham and Women’s Hospital are combining a version of the herpes virus with an immunostimulant that brings cancer-fighting molecules to the affected area in the brain, and check-point inhibitors to suppress the cancer’s ability to trick the immune system.
Dr. Zemmoura of Centre Hospitalier Universitaire de Tours, France and colleagues have evaluated a hypnosis technique in 37 patients who were undergoing awake brain surgery (or craniotomy), mainly for low-grade gliomas. Data was collected from 43 surgeries conducted between 2011-2015.